Healthcare is one of the most active M&A sectors with more than xx transactions closed in 2021. Since the start of the pandemic, investors have maintained a particularly high level of interest in the pharmaceuticals, life sciences, and healthcare services sectors. These transactions are driven by everything from market disruption to “simple” market consolidation. Our primary focus is in: Pharmaceuticals, healthcare equipment, healthcare supplies, distributors (of equipment and supplies), biotechnology, healthcare facilities and healthcare services.
We mostly participate in transactions representing the seller(s) in the segment of small and medium-sized companies. In general, the price level for companies in the healthcare sector is relatively high. These products often generate high contribution margins: the market potential is frequently significant, and the markets are often less vulnerable to short-term fluctuations.
We recognise the importance of having a profound understanding of the sector in order to evaluate the clients’ business and be able to screen the market for relevant buyers.